Torrent Pharma to Raise Up to Rs 12,500 Cr via Bonds for JB Chemicals Deal

"The ‌company is in the process of finalising rates and the allocation of quantum for each maturity, and once these things are finalised, they would open the issue for bidding on the electronic platform," one of the bankers said.

Torrent Pharma did not reply to a Reuters email seeking comment. The bankers requested anonymity ‌as they ‍are not authorised to speak to media.

The bond issue ‍has been rated AA+ by India Ratings and ‌Research, which said the deal will lift Torrent Pharma's ranking in the domestic market to fifth from seventh by market share. Torrent has agreed to acquire a controlling stake in JB at an equity valuation of about 257 billion rupees on a fully diluted basis, to be followed by a merger of the two ‍companies.

Also Read: Indian Pharma Market Posts 9% Surge in November Even as Volumes Stay Flat: PharmaTrac

The bond sale would be the largest rated fund-raising so far this financial year, which runs from April ‍to March, ⁠extending a trend ⁠of acquisitions being financed through domestic bond markets. JSW Group raised 70 billion rupees via zero-coupon bonds in September to fund the purchase of up to a 75% stake in the Indian unit of Dutch paint maker Akzo Nobel.

Two Jubilant Bhartia Group subsidiaries raised a combined 56.50 billion rupees through zero-coupon bonds in June to fund the acquisition of a 40% stake in Hindustan Coca-Cola Holdings.